ImpediMed (ASX:IPD) Price Target Decreased by 30.46% to 0.05

Average one-year price target for ImpediMed (ASX:IPD) was cut to $0.05/share, a decline of 30.46% from the prior $0.07 target dated Feb 21, 2026. This figure is an average of multiple analyst targets and signals a materially weaker analyst outlook for the stock. The revision is negative for sentiment around IPD but is analyst-level news unlikely to move broader markets.

Analysis

Average one-year price target for ImpediMed (ASX:IPD) was cut to $0.05/share, a decline of 30.46% from the prior $0.07 target dated Feb 21, 2026. This figure is an average of multiple analyst targets and signals a materially weaker analyst outlook for the stock. The revision is negative for sentiment around IPD but is analyst-level news unlikely to move broader markets.